Clinical trial
A Study Comparing Two Forms of Didanosine in HIV-infected Patients
NCT00002360 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00002360 |
|---|---|
| Title | A Study Comparing Two Forms of Didanosine in HIV-infected Patients |
| Official title | Pivotal Bioequivalence Study of Videx Chewable/Dispersible Buffered Tablets and an Encapsulated Enteric Coated Bead Formulation of Didanosine in HIV-Infected Subjects |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Didanosine |
| Enrollment | 30 |
| Start date | Mar 1, 1999 |
| Primary completion | Mar 1, 1999 |
| Completion | Mar 1, 1999 |
| First posted | Aug 31, 2001 |
| Last update posted | Apr 14, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: